We are live on ! Find out more
AH

Aviva Holdings Portfolio holdings

AUM $20.5M
1-Year Est. Return 117.01%
This Fund
S&P 500
This Quarter Est. Return
+29.98%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$478M
AUM Growth
+$22.3M
Cap. Flow
-$108M
Cap. Flow %
-22.56%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
1
Avg Time Held
6.8 quarters
Top 10 Avg Time Held
6.8 quarters
Top 20 Avg Time Held
6.8 quarters

Top Buys

Rank Stock Value
1
INSG icon
Inseego
INSG
+$14.9M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$91.3M
2
ESPR icon
Esperion Therapeutics
ESPR
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 75.07%
2 Technology 22.01%
3 Miscellaneous 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$323M 67.56%
3,135,966
– –
2015 Q4
14 quarters
INSG icon
2
Inseego
INSG
$80.5M
$105M 22.01%
2,196,550
+316,627
+17% +$14.9M
2018 Q3
3 quarters
MDCO
3
DELISTED
Medicines Co
MDCO
$35.8M 7.5%
982,831
-2,795,911
-74% -$91.3M
2017 Q1
9 quarters
SLDB icon
4
Solid Biosciences
SLDB
$737M
$66K 0.01%
766
– –
2018 Q2
4 quarters
ESPR icon
5
DELISTED
Esperion Therapeutics
ESPR
– –
-441,649
Closed -$17.7M –

Similar funds

MFAM
M Financial Asset Management Portland, Oregon $20.6M AUM 4.99% 1-Year Est. Return
SL
Stevard LLC Chicago, Illinois $26.8M AUM 42.43% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CGI
Calixto Global Investors Coral Gables, Florida $30.7M AUM 111.27% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return

Aviva Holdings's Q2 2019 Portfolio in Review

As of Q2 2019, Aviva Holdings held 6 positions worth $478M, up 4.9% from $456M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Aviva Holdings withdrew a net $108M in Q2 2019, closing 1 position and reducing 1 holding. Its most notable exit was Esperion Therapeutics, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 78% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Aviva Holdings added an estimated $14.9M to Inseego.

  • Aviva Holdings added most to Inseego in Q2 2019, an estimated $14.9M increase.
  • Aviva Holdings's biggest Q2 2019 reduction was Medicines Co, cutting an estimated $91.3M.
  • Aviva Holdings fully exited Esperion Therapeutics in Q2 2019, selling an estimated $17.7M.
  • Aviva Holdings's ten largest holdings make up 100% of its $478M portfolio in Q2 2019.
  • Aviva Holdings opened 0 new positions and closed 1 in Q2 2019.
  • Aviva Holdings's portfolio value rose 4.9% quarter-over-quarter to $478M.

Based on Aviva Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.